| 摘要 |
<p>D.P.C. 6094 Novel Spiro-oxazolidindiones Novel spiro-oxazolidindiones useful as aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications are disclosed. Pharmaceutical compositions containing the novel compounds and a method of treating chronic diabetic complications are also disclosed.</p> |
